2016 International Congress Archives - Page 31 of 207

12:00pm-1:30pm: Magnetic resonance imaging of nigrosome-1 in the diagnosis of early Parkinson’s: Initial results of the Parkinson’s magnetic imaging repository (PaMIR)

S.T. Schwarz, Y. Xing, A. Martin Bastida, C. Lakmali Sugathapala, M. Silverdale, J. Mclean, R. Jampana, N. Bajaj, D. Burn, P. Piccini, D. Grosset, D.P. Auer (Nottingham, United Kingdom)

Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Maintenance of balance function in patients with HD treated with deutetrabenazine, as measured by Berg balance test (BBT) in First-HD

D.O. Claassen, D. Oakes, D. Stamler, V. Sung, C.M. Testa, S. Frank, On behalf of the First-HD HSG Investigators (Nashville, TN, USA)

Huntington's disease · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Manual MRI morphometry in Parkinsonian syndromes

L. Möller, J. Kassubek, M. Südmeyer, R. Hilker, E. Hattingen, K. Egger, F. Amtage, G. Respondek, M. Stamelou, A. Schnitzler, W.H. Oertel, S. Knake, H.J. Huppertz, G.U. Höglinger (Marburg, Germany)

Imaging and Neurophysiology

12:00pm-1:30pm: May substantia nigra volume asymmetry be an indicator of motor asymmetry in Parkinson’s disease? A retrospective analysis

N.F. Durmaz, M. Yorubulut, C.M. Akbostanci (Ankara, Turkey)

Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Memory compensation strategies in patients with Parkinson’s disease

C.C. Walton, J.Y.Y. Szeto, L. Mowszowski, S.J.G. Lewis, S.L. Naismith (Sydney, Australia)

Cognitive disorders · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Metabolic brain changes related to specific cognitive impairment in non-demented Parkinson’s disease patients

M. Trošt, S. Brezovar, C.C. Tang, D. Eidelberg, N. Zupancic Kriznar, M. Gregoric Kramberger, P. Tomše, Z. Pirtošek (Ljubljana, Slovenia)

Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Mild cognitive impairment in Parkinson’s disease: Impact on caregiver outcomes

J.Y.Y. Szeto, M. Gilat, C.C. Walton, L. Mowszowski, S.L. Naismith, S.J.G. Lewis (Sydney, Australia)

Parkinson's disease: Cognition · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Mild cognitive impairment is linked with white matter degeneration in the cortico-subcortical tracts in patients with Parkinson’s disease

A. Hanganu, J.C. Houde, V.S. Fonov, C. Degroot, B. Mejia-Constain, A.L. Lafontaine, V. Soland, S. Chouinard, L.D. Collins, M. Descoteaux, O. Monchi (Calgary, Canada)

Cognition and Psychiatry

12:00pm-1:30pm: Mirror movements in Moebius syndrome: Mirroring beyond movements

H.J.S. Cho, P. Panyakaew, M. Hallett (Bethesda, MD, USA)

Neurophysiology (non-PD) · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: MMSE and MoCA feasibility in Parkinson’s disease and dementia with Lewy bodies: A multicenter 1-year follow-up study

R. Biundo, L. Weis, S. Bostantjopoulou, E. Stefanova, C. Falup-Pecurariu, M.G. Kramberger, G. Geurtsen, A. Antonini, D. Weintraub, D. Aarsland (Venice, Italy)

Cognitive disorders · Exhibit Hall located in Hall B, Level 2